Coverage of medical research, clinical studies, scientific discoveries and academic developments from Türkiye and the global medical community.

Bayer has selected six startups from 310 applicants for the 2026 edition of its G4A Accelerator Program in Türkiye. The participants will receive a 100-day acceleration program, mentorship, business development support, and opportunities to collaborate with Bayer.

Brain development does not end with adolescence, according to neurologist Dr. Oğuzhan Onultan, who said emerging neuroscience research suggests that regions responsible for decision-making and impulse control in the male brain may continue to mature into the early 30s.